Skip to content

Sultopride

NERVOUS SYSTEM

Also known as: (+/-)-Sultopride, barnetil, sultopride HCl, sultopride hydrochloride

ATC N05AL02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Sultopride is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including DRD2 and DRD3.

  • Molecular targets: DRD2 and DRD3 (2 listed in DrugCentral).
  • ATC code: N05AL02 (Benzamides).
  • Molecular formula: C17H26N2O4S; molecular weight 354.47 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
D(2) dopamine receptorDRD2unknownKi 8.57
D(3) dopamine receptorDRD3unknownKi 8.42

ATC classification

ATC codeTherapeutic hierarchy
N05AL02NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Benzamides

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Sultopride is on its molecule page.

Molecular formulaC17H26N2O4S
Molecular weight354.47 g/mol
CAS number53583-79-2
InChIKeyUNRHXEPDKXPRTM-UHFFFAOYSA-N
PubChem CID5357
CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(=O)(=O)CC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Sultopride work?

Its molecular targets in DrugCentral include DRD2 and DRD3.

What is the chemical formula of Sultopride?

Sultopride has the molecular formula C17H26N2O4S and a molecular weight of 354.47 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications0
FormulaC17H26N2O4S
DrugCentral ID2541
Interactive profile